HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiang Li Selected Research

MX1520

6/2004Anti-sickling effect of MX-1520, a prodrug of vanillin: an in vivo study using rodents.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiang Li Research Topics

Disease

521Neoplasms (Cancer)
12/2022 - 11/2004
119Inflammation (Inflammations)
09/2022 - 12/2004
98Infections
04/2022 - 09/2006
78Neoplasm Metastasis (Metastasis)
12/2022 - 10/2006
65Breast Neoplasms (Breast Cancer)
01/2022 - 09/2007
58Hypoxia (Hypoxemia)
04/2022 - 06/2004
55Prostatic Neoplasms (Prostate Cancer)
02/2021 - 05/2002
54Carcinogenesis
03/2022 - 09/2004
43Hepatocellular Carcinoma (Hepatoma)
12/2022 - 01/2010
35Wounds and Injuries (Trauma)
11/2022 - 10/2005
34Fibrosis (Cirrhosis)
11/2022 - 06/2007
33Carcinoma (Carcinomatosis)
01/2021 - 01/2002
31Colorectal Neoplasms (Colorectal Cancer)
10/2022 - 01/2015
30Atherosclerosis
04/2022 - 08/2009
29Lung Neoplasms (Lung Cancer)
06/2022 - 12/2007
29Pain (Aches)
05/2022 - 10/2008
28Cardiovascular Diseases (Cardiovascular Disease)
09/2022 - 01/2010
27Brain Injuries (Brain Injury)
10/2022 - 09/2009
27Pancreatic Neoplasms (Pancreatic Cancer)
09/2022 - 01/2013
27Hypertension (High Blood Pressure)
01/2022 - 07/2007
26Myocardial Infarction
06/2022 - 04/2007
25Sepsis (Septicemia)
09/2022 - 12/2004
25Renal Cell Carcinoma (Grawitz Tumor)
01/2022 - 01/2009
24Ischemic Stroke
06/2022 - 10/2003
24Ischemia
06/2022 - 10/2003
23Body Weight (Weight, Body)
12/2022 - 01/2013
22Stroke (Strokes)
04/2022 - 10/2003
21COVID-19
04/2022 - 01/2020
21Virus Diseases (Viral Diseases)
01/2022 - 01/2010
20Stomach Neoplasms (Stomach Cancer)
12/2022 - 01/2012
19Urinary Bladder Neoplasms (Bladder Cancer)
06/2022 - 02/2004
19Reperfusion Injury
06/2022 - 08/2007
19Cognitive Dysfunction
01/2022 - 01/2017
18Heart Failure
01/2022 - 02/2012
17Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
06/2022 - 10/2008
17Type 2 Diabetes Mellitus (MODY)
01/2022 - 06/2006
16Necrosis
08/2022 - 04/2009
16Brain Edema (Cerebral Edema)
03/2022 - 11/2016
16Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2022 - 06/2013
15Diabetes Mellitus
06/2022 - 06/2006
15Brain Ischemia (Cerebral Ischemia)
06/2022 - 01/2012
15Obesity
01/2022 - 12/2015
15Traumatic Brain Injuries (Traumatic Brain Injury)
01/2022 - 01/2016
15Atherosclerotic Plaque (Atheroma)
01/2022 - 01/2012
15Thrombosis (Thrombus)
12/2021 - 04/2007
15Adenocarcinoma
09/2021 - 03/2005
14Coronary Artery Disease (Coronary Atherosclerosis)
04/2022 - 06/2006
14Hemorrhage
02/2022 - 04/2013

Drug/Important Bio-Agent (IBA)

172Proteins (Proteins, Gene)FDA Link
12/2022 - 11/2006
99Pharmaceutical PreparationsIBA
05/2022 - 01/2009
77Biomarkers (Surrogate Marker)IBA
04/2022 - 10/2007
62Biological ProductsIBA
11/2022 - 09/2004
53Glucose (Dextrose)FDA LinkGeneric
11/2022 - 06/2006
52MicroRNAs (MicroRNA)IBA
11/2022 - 10/2011
48Messenger RNA (mRNA)IBA
09/2022 - 08/2005
47CytokinesIBA
09/2022 - 02/2004
37Therapeutic UsesIBA
04/2022 - 01/2012
32Peptides (Polypeptides)IBA
01/2022 - 10/2008
30LipidsIBA
10/2022 - 07/2007
30Oxygen (Dioxygen)IBA
05/2022 - 10/2005
28Reactive Oxygen Species (Oxygen Radicals)IBA
09/2022 - 01/2010
27Transcription Factors (Transcription Factor)IBA
09/2022 - 01/2008
26Small Interfering RNA (siRNA)IBA
06/2022 - 02/2008
26EnzymesIBA
01/2022 - 08/2007
24Interleukin-6 (Interleukin 6)IBA
08/2022 - 10/2010
23RNA (Ribonucleic Acid)IBA
05/2022 - 02/2008
21Long Noncoding RNAIBA
05/2022 - 07/2014
21InflammasomesIBA
01/2022 - 07/2012
21Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 01/2012
21CholesterolIBA
01/2022 - 07/2007
20Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2022 - 01/2009
19Phosphotransferases (Kinase)IBA
01/2022 - 04/2007
19DNA (Deoxyribonucleic Acid)IBA
01/2022 - 02/2008
18Anti-Bacterial Agents (Antibiotics)IBA
04/2022 - 05/2012
18AcidsIBA
02/2022 - 09/2008
17AntioxidantsIBA
12/2022 - 08/2006
17Indicators and Reagents (Reagents)IBA
12/2022 - 12/2011
16VaccinesIBA
04/2022 - 01/2011
16Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
02/2022 - 09/2012
16CreatinineIBA
01/2022 - 07/2007
16DecitabineFDA Link
01/2021 - 01/2012
15AntibodiesIBA
12/2022 - 08/2004
15LigandsIBA
06/2022 - 01/2010
15Circular RNAIBA
03/2022 - 07/2017
15Neuroprotective AgentsIBA
03/2022 - 01/2016
15Insulin (Novolin)FDA Link
02/2021 - 05/2008
14Polysaccharides (Glycans)IBA
12/2022 - 08/2005
14Fatty Acids (Saturated Fatty Acids)IBA
12/2022 - 02/2009
14Immune Checkpoint InhibitorsIBA
12/2022 - 01/2018
14SolutionsIBA
06/2022 - 11/2006
14CalciumIBA
02/2022 - 08/2006
14AntigensIBA
01/2022 - 03/2005

Therapy/Procedure

247Therapeutics
12/2022 - 12/2004
68Drug Therapy (Chemotherapy)
06/2022 - 05/2011
39Immunotherapy
06/2022 - 01/2010
22Radiotherapy
09/2022 - 09/2007
16Chinese Traditional Medicine (Traditional Chinese Medicine)
09/2022 - 06/2010
16Length of Stay
04/2022 - 04/2013
16Transplantation
01/2022 - 07/2012
14Precision Medicine
08/2022 - 05/2015